Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples